| Hans-Günter Meyer-Thompson | Hepatitiden
Global HCV and HIV Treatment Restrictions Group. Direct-acting antiviral therapies for hepatitis C infection: global registration, reimbursement, and restrictions.
Global HCV and HIV Treatment Restrictions Group. Direct-acting antiviral therapies for hepatitis C infection: global registration, reimbursement, and restrictions.
Marshall AD, Willing AR, Kairouz A, Cunningham EB, Wheeler A, O'Brien N, Perera V, Ward JW, Hiebert L, Degenhardt L, Hajarizadeh B, Colledge S, Hickman M, Jawad D, Lazarus JV, Matthews GV, Scheibe A, Vickerman P, Dore GJ, Grebely J;
Lancet Gastroenterol Hepatol. 2024 Feb 14:S2468-1253(23)00335-7. doi: 10.1016/S2468-1253(23)00335-7. Epub ahead of print. PMID: 38367631.
Abstract mit freiem Zugang nach Registrierung
https://www.thelancet.com/journals/langas/article/PIIS2468-1253(23)00335-7/abstracthttps://www.thelancet.com/journals/langas/article/PIIS2468-1253(23)00335-7/abstract